INTERNATIONAL PATENT: PASSAGE BIO, INC. FILES APPLICATION FOR "RECOMBINANT ADENO-ASSOCIATED VIRUS FOR TREATMENT OF NEURODEGENERATIVE DISORDERS"

GENEVA, Sept. 17 -- PASSAGE BIO, INC. (One Commerce Square2005 Market Street, 39th FloorPhiladelphia, PA 19103) filed a patent application (PCT/US2025/018143) for "RECOMBINANT ADENO-ASSOCIATED VIRUS FOR TREATMENT OF NEURODEGENERATIVE DISORDERS" on Mar 03, 2025. With publication no. WO/2025/188625, the details related to the patent application was published on Sep 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BROWNE, Susan, E. (c/o Passage Bio, Inc.One Commerce Square2005 Market Street, 39th FloorPhiladelphia, PA 19103), CHOU, William (c/o Passage Bio, Inc.One Commerce Square2005 Market...